The Global Connected Drug Delivery Devices Market Size is estimated to register 30.4% growth over the forecast period from 2023 to 2030.
The market growth is driven by the increasing focus on patient-centric healthcare, and connected drug delivery devices help in providing personalized treatment and monitoring for patients. This trend is driven by the desire to improve patient adherence to treatment regimens and outcomes. Leading companies that are focusing on the Expansion of Indications, Biologics Specialty Drugs, Smart Inhalers and Injectors, Miniaturization and Wearables, Telehealth Integration, and others to boost market shares in the industry.
The Connected Drug Delivery Devices Market is a rapidly evolving sector driven by patient-centric care, the rise of chronic diseases, technological advancements, and regulatory support. These devices, including smart inhalers, insulin pens, and pill dispensers, offer enhanced medication administration and monitoring capabilities. However, challenges such as data security, integration with healthcare systems, and cost considerations must be addressed.
The integration of telehealth into the Connected Drug Delivery Devices Market offers improved patient access, medication adherence, and personalized treatment, reducing healthcare costs and enabling remote management. It fosters patient engagement, facilitates timely intervention, and extends specialized care to underserved areas, aligning with the trend toward patient-centric and efficient healthcare delivery.
The demand for connected drug delivery devices in home healthcare is growing due to an aging population with chronic illnesses, increased adoption of telehealth and remote monitoring, and the need for cost-effective healthcare solutions. These devices empower patients to manage their medications effectively through real-time monitoring and reminders, improving treatment adherence and outcomes. As home healthcare services expand, connected drug delivery devices facilitate remote patient care by enabling healthcare providers to monitor medication adherence and patient health status, making them a crucial component of patient-centric, home-based healthcare solutions.
Remote clinical trials are crucial in the Connected Drug Delivery Devices Market, as they leverage connected drug delivery devices to monitor medication usage and patient health status remotely, streamlining the trial process, improving data accuracy, and reducing the need for physical site visits. These trials are especially valuable for gathering diverse patient data and identifying adverse events or non-adherence quickly.
The Global Connected Drug Delivery Devices Market is analyzed across Standalone Components and software, Integrated Devices, and others. Of these, Standalone Components and software are poised to register the fastest growth. In the Connected Drug Delivery Devices Market, standalone components like smart inhalers, insulin pens, and pill dispensers, equipped with sensors and communication modules, work in conjunction with software including mobile apps, cloud platforms, and data analytics tools.
The Global Connected Drug Delivery Devices Market is analyzed across a wide range of routes of Administration including Parenteral, Inhalational, and others. Of these, Inhalational held a significant market share in 2023. In the Connected Drug Delivery Devices Market, inhalational drug delivery devices are essential for precise medication administration to the respiratory system, particularly for conditions like asthma and COPD. These devices, including smart inhalers with sensors and connectivity features, ensure accurate dosing, real-time feedback, and medication adherence reminders for patients.
By Type
By Route of Administration
By Application
By Region
* List not exhaustive
1. Executive Summary
1.1 Introduction to Connected Drug Delivery Devices Markets
1.2 Connected Drug Delivery Devices Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in the Connected Drug Delivery Devices Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Connected Drug Delivery Devices Market Trends
3.1.1 Potential advantages for stakeholders across the industry
3.1.2 Rising Prevalence of Chronic Diseases
3.1.3 Foray of New players
3.2 Key Connected Drug Delivery Devices Market Growth Drivers
3.2.1 Increasing Geriatric population and growing healthcare expenditures
3.2.2 Connected inhaler sensors present strong market potential
3.2.3 Rapid growth of Telemedicine supports market growth
3.3 Key Connected Drug Delivery Devices Market Growth Restraints
3.3.1 Safety, Security, and Environmental Regulations
3.3.2 Lack of trained personnel
3.3.3 Lack of awareness in developing countries
4 Connected Drug Delivery Devices Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts: Connected Drug Delivery Devices Market Size Outlook to 2030
4.2 Reference Growth Case Scenario Forecasts: Connected Drug Delivery Devices Market Size Outlook to 2030
4.3 High Growth Case Scenario Forecasts: Connected Drug Delivery Devices Market Size Outlook to 2030
5. Connected Drug Delivery Devices Market Segmentation- Outlook by Type
5.1 Connected Drug Delivery Devices Market Share Analysis by Type, 2023
5.2 Connected Sensors Market Outlook to 2030
5.3 Integrated Connected Devices Market Outlook to 2030
6. Connected Drug Delivery Devices Market Segmentation- Outlook by Technology
6.1 Connected Drug Delivery Devices Market Share Analysis by Technology, 2023
6.2 Bluetooth Connected Drug Delivery Devices Market Outlook to 2030
6.3 NFC Connected Drug Delivery Devices Market Outlook to 2030
6.4 Wi-Fi Connected Drug Delivery Devices Market Outlook to 2030
7. Connected Drug Delivery Devices Market Segmentation- Outlook by Application
7.1 Connected Drug Delivery Devices Market Share Analysis by Application, 2023
7.2 Hospital: Connected Drug Delivery Devices Market Outlook to 2030
7.3 Clinics: Connected Drug Delivery Devices Market Outlook to 2030
7.4 Homecare: Connected Drug Delivery Devices Market Outlook to 2030
8. North America Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Connected Drug Delivery Devices Market Growth Opportunities
8.2.1 North America Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
8.2.2 North America Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
8.2.3 North America Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
8.3 United States Connected Drug Delivery Devices Market Outlook, 2021 to 2030
8.4 Canada Connected Drug Delivery Devices Market Outlook, 2021 to 2030
8.5 Mexico Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9. Europe Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Connected Drug Delivery Devices Market Growth Opportunities
9.2.1 Europe Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
9.2.2 Europe Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
9.2.3 Europe Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
9.3 Germany Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.4 France Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.5 United Kingdom Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.6 Spain Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.7 Italy Connected Drug Delivery Devices Market Outlook, 2021 to 2030
9.8 Other Europe Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10. Asia Pacific Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Connected Drug Delivery Devices Market Growth Opportunities
10.2.1 Asia Pacific Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
10.2.2 Asia Pacific Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
10.2.3 Asia Pacific Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
10.3 China Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.4 Japan Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.5 India Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.6 South Korea Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.7 Indonesia Connected Drug Delivery Devices Market Outlook, 2021 to 2030
10.8 Other Asia Pacific Connected Drug Delivery Devices Market Outlook, 2021 to 2030
11. South and Central America Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 South and Central America Connected Drug Delivery Devices Market Growth Opportunities
11.2.1 South and Central America Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
11.2.2 South and Central America Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
11.2.3 South and Central America Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
11.3 Brazil Connected Drug Delivery Devices Market Outlook, 2021 to 2030
11.4 Argentina Connected Drug Delivery Devices Market Outlook, 2021 to 2030
11.5 Other Latin America Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12. Middle East and Africa Connected Drug Delivery Devices Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and Africa Connected Drug Delivery Devices Market Growth Opportunities
12.2.1 Middle East and Africa Connected Drug Delivery Devices Market Outlook by Type, 2021 to 2030
12.2.2 Middle East and Africa Connected Drug Delivery Devices Market Outlook by Application, 2021 to 2030
12.2.3 Middle East and Africa Connected Drug Delivery Devices Market Outlook by Country, 2021 to 2030
12.3 Saudi Arabia Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.4 United Arab Emirates (the UAE) Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.5 Other Middle East Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.6 Egypt Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.7 South Africa Connected Drug Delivery Devices Market Outlook, 2021 to 2030
12.8 Other Africa Connected Drug Delivery Devices Market Outlook, 2021 to 2030
13. Profiles of major world Connected Drug Delivery Devices Companies
13.1 Phillips Medisize
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.2 Teva Pharmaceutical Industries Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.3 Propeller Health
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.4 Elcam Medical
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.5 Merck KGaA
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.6 West Pharmaceutical Services, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.7 BIOCORP
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
13.8 Aterica
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
- Financial Profile
13.9 Adherium Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Profile
- Financial Profile
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
By Type
By Route of Administration
By Application
By Region
Potential advantages for stakeholders across the industry; Rising Prevalence of Chronic Diseases; Increasing Geriatric population and growing healthcare expenditures; connected inhaler sensors present strong market potential; Rapid growth of Telemedicine supports market growth;
The global Connected Drug Delivery Devices Market Size stood at US$ 1.8 Billion in 2022
The global Connected Drug Delivery Devices Market Size is poised to register 21.6% growth over the forecast period from 2023 to 2030
Phillips Medisize, Teva Pharmaceutical Industries Ltd, Propeller Health, Elcam Medical, Merck KGaA, West Pharmaceutical Services Inc, BIOCORP, Aterica, Adherium Ltd.
Connected Sensors held the largest share of around two-thirds of market revenue in the global markets